According to BlockBeats, Huajian Medical, a Hong Kong-listed company, announced a temporary halt to its significant cryptocurrency acquisition plan initially proposed in mid-August. The plan involved purchasing up to 3 billion yuan worth of cryptocurrency, pending shareholder approval. However, the company has not sent the circular to shareholders as expected, and there has been no progress for two and a half months.
Huajian Medical stated that additional time is needed to obtain shareholder authorization, leading to the suspension of the acquisition. The company indicated that any future purchases of Ethereum (ETH) will be disclosed in accordance with the Hong Kong Stock Exchange listing rules, particularly Chapter 14, which requires transaction disclosure.
Furthermore, Huajian Medical plans to develop an AI algorithm platform to enhance recognition rates. The company aims to integrate its distribution network, ecosystem, and RWA platform to improve the accuracy of underlying asset valuation models and increase the efficiency and transparency of the securitization process.
